Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Search Results for antiviral

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19

Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious […]

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
4 weeks ago
Share

University of Liverpool Led Preclinical Research Indicates Thapsigargin Powerful Antiviral Impact on SARS-CoV-2

Based on preclinical research in cell cultures and animals, a team of investigators at the University of Nottingham in England […]

University of Liverpool Led Preclinical Research Indicates Thapsigargin Powerful Antiviral Impact on SARS-CoV-2
4 weeks ago
Share

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir

With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir
2 months ago
Share

Clinical Trials and Research News Weekly Roundup | Treat COVID-19 Patients Early Antiviral Cocktail?

  Top Doctor at University of Hong Kong Suggests Aggressively Treat COVID-19 Patients Early with Antiviral Cocktail Medications: Hong Kong’s […]

TrialSite News Roundup
4 months ago
Share

Top Doctor at University of Hong Kong Suggests Aggressively Treat COVID-19 Patients Early with Antiviral Cocktail Medications

Hong Kong’s medical community knows something about coronaviruses given its experience with the first SARS 17 years ago and of […]

Top Doctor at University of Hong Kong Suggests Aggressively Treat COVID-19 Patients Early with Antiviral Cocktail Medications
5 months ago
Share

Pfizer Takes Antiviral Drug PF-07304814 into Phase 1 Clinical Trial Targeting COVID-19

Pfizer has initiated a Phase 1 clinical trial for a novel small molecule called PF-07304814, a compound targeting an enzyme […]

Pfizer Takes Antiviral Drug PF-07304814 into Phase 1 Clinical Trial Targeting COVID-19
5 months ago
Share

NIH to Conduct Preclinical Studies of GS-441524, Gilead’s Possibly Superior Antiviral Thanks to Public Citizen Pressure

Early in August, TrialSite highlighted that consumer advocacy organizations such as Public Citizen continue to pester federal research agencies to pressure […]

NIH to Conduct Preclinical Studies of GS-441524, Gilead’s Possibly Superior Antiviral Thanks to Public Citizen Pressure
6 months ago
Share

Important Collaborative Forms as AbbVie Invests $30m & Taps into the Brain Power of Harvard Medical School to Develop new Antivirals

AbbVie (NYSE:ABBV) and Harvard University announced a $30 million collaborative research alliance involving the launch of a multi-prong initiative at […]

Important Collaborative Forms as AbbVie Invests $30m & Taps into the Brain Power of Harvard Medical School to Develop new Antivirals
6 months ago
Share

Korea’s Chungnam National University Teams with Celltrion to Launch Clinical Trials Program Investigating Antiviral Antibody Treatment

South Korea’s Chungnam National University has come together with prominent biotech company Celltrion to launch a Phase 1 clinical trial of a […]

Korea’s Chungnam National University Teams with Celltrion to Launch Clinical Trials Program Investigating Antiviral Antibody Treatment
7 months ago
Share

Merck Positioning to Take the Lead U.S. COVID-19 Antiviral Market from Remdesivir: EIDD-2801

In May, Merck announced a collaboration with Ridgeback Biopharmaceuticals LP (Ridgeback) to jointly develop EIDD-2801, an orally available antiviral candidate […]

Merck Positioning to Take the Lead U.S. COVID-19 Antiviral Market from Remdesivir: EIDD-2801
7 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.